These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
615 related articles for article (PubMed ID: 25208622)
21. Lipocalin-type prostaglandin D synthase/beta-trace is a major amyloid beta-chaperone in human cerebrospinal fluid. Kanekiyo T; Ban T; Aritake K; Huang ZL; Qu WM; Okazaki I; Mohri I; Murayama S; Ozono K; Taniike M; Goto Y; Urade Y Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6412-7. PubMed ID: 17404210 [TBL] [Abstract][Full Text] [Related]
22. Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice. Rijal Upadhaya A; Capetillo-Zarate E; Kosterin I; Abramowski D; Kumar S; Yamaguchi H; Walter J; Fändrich M; Staufenbiel M; Thal DR Neurobiol Aging; 2012 Nov; 33(11):2641-60. PubMed ID: 22305478 [TBL] [Abstract][Full Text] [Related]
23. Correlation of Aβ deposition in the nasal cavity with the formation of senile plaques in the brain of a transgenic mouse model of Alzheimer's disease. Kameshima N; Nanjou T; Fukuhara T; Yanagisawa D; Tooyama I Neurosci Lett; 2012 Apr; 513(2):166-9. PubMed ID: 22343315 [TBL] [Abstract][Full Text] [Related]
24. Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease. Moon M; Hong HS; Nam DW; Baik SH; Song H; Kook SY; Kim YS; Lee J; Mook-Jung I J Alzheimers Dis; 2012; 29(3):615-28. PubMed ID: 22269161 [TBL] [Abstract][Full Text] [Related]
25. Mutant ubiquitin decreases amyloid β plaque formation in a transgenic mouse model of Alzheimer's disease. van Tijn P; Dennissen FJ; Gentier RJ; Hobo B; Hermes D; Steinbusch HW; Van Leeuwen FW; Fischer DF Neurochem Int; 2012 Oct; 61(5):739-48. PubMed ID: 22797007 [TBL] [Abstract][Full Text] [Related]
26. Cytoplasmic gelsolin in pheochromocytoma-12 cells forms a complex with amyloid beta-protein. Ji L; Chauhan A; Chauhan V Neuroreport; 2008 Mar; 19(4):463-6. PubMed ID: 18287947 [TBL] [Abstract][Full Text] [Related]
27. Efficient near-infrared in vivo imaging of amyoid-β deposits in Alzheimer's disease mouse models. Schmidt A; Pahnke J J Alzheimers Dis; 2012; 30(3):651-64. PubMed ID: 22460331 [TBL] [Abstract][Full Text] [Related]
28. Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Abeta oligomerization. De Felice FG; Vieira MN; Saraiva LM; Figueroa-Villar JD; Garcia-Abreu J; Liu R; Chang L; Klein WL; Ferreira ST FASEB J; 2004 Sep; 18(12):1366-72. PubMed ID: 15333579 [TBL] [Abstract][Full Text] [Related]
29. Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease. Watson D; Castaño E; Kokjohn TA; Kuo YM; Lyubchenko Y; Pinsky D; Connolly ES; Esh C; Luehrs DC; Stine WB; Rowse LM; Emmerling MR; Roher AE Neurol Res; 2005 Dec; 27(8):869-81. PubMed ID: 16354549 [TBL] [Abstract][Full Text] [Related]
30. Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer's Disease. Behl T; Kaur I; Fratila O; Brata R; Bungau S Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050199 [TBL] [Abstract][Full Text] [Related]
38. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis. Bloom GS JAMA Neurol; 2014 Apr; 71(4):505-8. PubMed ID: 24493463 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of glutaminyl cyclase ameliorates amyloid pathology in an animal model of Alzheimer's disease via the modulation of γ-secretase activity. Song H; Chang YJ; Moon M; Park SK; Tran PT; Hoang VH; Lee J; Mook-Jung I J Alzheimers Dis; 2015; 43(3):797-807. PubMed ID: 25114069 [TBL] [Abstract][Full Text] [Related]